Oncology outpatients with pain from bone metastasis require more than around-the-clock dosing of analgesics to achieve adequate pain control
- 1 February 2002
- journal article
- research article
- Published by Elsevier in The Journal of Pain
- Vol. 3 (1) , 12-20
- https://doi.org/10.1054/jpai.2002.27002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.European Journal of Clinical Pharmacology, 1999
- High-Dose Tramadol in Comparison to Low-Dose Morphine for Cancer Pain ReliefJournal of Pain and Symptom Management, 1999
- Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer painSupportive Care in Cancer, 1999
- Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.Cancer Investigation, 1998
- Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer painJournal of Pain and Symptom Management, 1997
- Differences in patientsʼ and family caregiversʼ perceptions of the pain experience influence patient and caregiver outcomesPain, 1997
- Ethical Issues in Pain ManagementThe Hospice Journal, 1997
- Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer painCancer, 1997
- Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer painPain, 1997
- Mood states of oncology outpatients: Does pain make a difference?Journal of Pain and Symptom Management, 1995